🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Florid › Deltona

Etid klinik pou Dyabèt Tip 2 nan Deltona, FL

10 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Deltona (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Ap rekriteFaz 3
  • Optimal Research Sites, Orange City · 4 mi lwen
  • Adult Medicine of Lake County, Inc, Mt. Dora · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Hillcrest Medical Research, DeLand · 9 mi lwen
  • University Clinical Research Deland, LLC, DeLand · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Ap rekriteFaz 1
  • Progressive Medical Research, Port Orange · 23 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07223333

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Adult Medicine of Lake County, Inc., Mt. Dora · 24 mi lwen
  • Arrow Clinical Trials, Daytona Beach · 26 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Daytona Beach · 26 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Progressive Medical Research, Port Orange · 23 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • Progressive Medical Research, Port Orange · 23 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Velocity Clinical Research, New Smyrna Beach, Edgewater · 23 mi lwen
  • Progressive Medical Research, Port Orange · 23 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • Accel Research Sites - DeLand, DeLand · 9 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Ap rekriteFaz 2
  • Velocity Clinical Research New Smyrna Beach, Edgewater · 23 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Deltona

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.